Please register to participate in our discussions with 2 million other members - it's free and quick! Some forums can only be seen by registered members. After you create your account, you'll be able to customize options and access all our 15,000 new posts/day with fewer ads.
Meh, I'm still skeptical of the whole death to cancer cell approach via a drug or gene therapy. This approach fails to see the even bigger picture, that cancer is not just unregulated growth, but a malfunction of the cellular system on a developmental level.
For example--why can you turn normal tissue cancerous by disrupting the extracellular matrix alone? The primary cause of inducing cancer in such experiments has nothing to do with say a mutated gene, but is purely mechanical in nature. Also, experiments conducted 35 years ago showed that if you mix cancer cells with embryonic mesenchymal stem cells, you can actually revert cancer cells back to normal cells. Quite interesting. What is it about the architecture of developing embryonic tissue that can revert cancer cells? The mechanobiological approach to cancer was kicked to the curb once people started to become fixated on molecular biology and specific genes in order to create therapies with single targets. Such a reductionist approach is probably why cancer therapies still stink. There's definitely something happening on a higher level than just one, two, or even 3 malfunctioning signaling pathways that cause cancer and allow it to proliferate. What's the role of extracellular matrix degradation? We know it plays a central role, so why are we spending so much effort on drug research rather than trying to build biomimetic materials of embryologic tissue to possibly revert cancer cells back to normal?
Two years ago, in experiments with mice, researchers showed that they could wipe out a cell's developmental "memory" by inserting just four genes. Once returned to its pristine, embryonic state, the cell could then be coaxed to become an altogether different type of cell.
The transformed cells grow and divide in the laboratory, unlike most adult cells, which don't survive in culture conditions. The cells could then be induced to assume new identities, including those cell types most affected by the diseases afflicting the patients who had donated the initial cells.
A third research team skipped the embryonic state altogether and, working with mouse cells, turned one type of mature pancreas cells, called exocrine cells, directly into another type, called beta cells.
Please register to post and access all features of our very popular forum. It is free and quick. Over $68,000 in prizes has already been given out to active posters on our forum. Additional giveaways are planned.
Detailed information about all U.S. cities, counties, and zip codes on our site: City-data.com.